ActiBioPure™,无动物源,无叠氮钠,无载体,生物活性,高性能 级 提供 ≥97%(SDS-PAGE&HPLC) 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存,避免反复冻融。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
CXCL9是一个缺乏ELR结构域的趋化因子α亚家族的成员，最初被确定为小鼠巨噬细胞中的淋巴因子激活基因。随后以小鼠MIG cDNA为探针克隆了人CXCL9。CXCL9基因在中枢神经系统的巨噬细胞和初级胶质细胞中被诱导，特别是在ifn - γ的反应中。CXCL9已被证明是活化T淋巴细胞和TIL的趋化剂，但对中性粒细胞或单核细胞则不是。人类CXCL9 cDNA编码一个125个氨基酸残基前体蛋白和一个22个氨基酸残基信号肽，该信号肽切割后生成一个103个氨基酸残基成熟蛋白。CXCL9具有一个扩展的羧基端，包含超过50%的碱性氨基酸残基，比大多数其他趋化因子都要大。CXCL9的羧基末端残基容易发生蛋白水解裂解，导致天然和重组CXCL9的大小不均匀。在钙通量测定中，羧基端大量缺失的CXCL9被证明具有较低的活性。一种特异性于CXCL9和IP-10的趋化因子受体(CXCR3)已被克隆，并显示在il -2激活的T淋巴细胞中高度表达。在研发系统中生产的大肠杆菌表达CXCL9制剂已被证明含有超过80%的全长CXCL9。
Purity
>97% SDS-PAGE. Purity is greater than 97% as determined by reducing SDS-PAGE
Function
Cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. Chemotactic for activated T-cells. Binds to CXCR3.
CXCL9, a member of the alpha subfamily of chemokines that lack the ELR domain, was initially identified as a lymphokine-activated gene in mouse macrophages. Human CXCL9 was subsequently cloned using mouse MIG cDNA as a probe. The CXCL9 gene is induced in macrophages and in primary glial cells of the central nervous system specifically in response to IFN-gamma. CXCL9 has been shown to be a chemoattractant for activated T‑lymphocytes and TIL but not for neutrophils or monocytes. The human CXCL9 cDNA encodes a 125 amino acid residue precursor protein with a 22 amino acid residue signal peptide that is cleaved to yield a 103 amino acid residue mature protein. CXCL9 has an extended carboxy‑terminus containing greater than 50% basic amino acid residues and is larger than most other chemokines. The carboxy‑terminal residues of CXCL9 are prone to proteolytic cleavage resulting in size heterogeneity of natural and recombinant CXCL9. CXCL9 with large carboxy‑terminal deletions have been shown to have diminished activity in the calcium flux assay. A chemokine receptor (CXCR3) specific for CXCL9 and IP-10 has been cloned and shown to be highly expressed in IL-2-activated T‑lymphocytes. The E. coli‑expressed CXCL9 preparations produced at R&D Systems have been shown to contain greater than 80% full length CXCL9.
Recombinant Human CXCL9 Protein (rp144872)-Protein Bioactivity
Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human peripheral blood T-lymphocytes is in a concentration range of 10-100 ng/mL.
Recombinant Human CXCL9 Protein (rp144872)-SDS-PAGE
Recombinant Human CXCL9 Protein was resolved with SDS-PAGE under reducing (R) and visualized by Coomassie® Blue staining, showing a single band at 16.8 kDa.
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 ZJ23F0600385 |
分析证书 | rp144872 |
| ZJ23F0600386 |
分析证书 | rp144872 |
| ZJ23F0600387 |
分析证书 | rp144872 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Bioactive 级别指南 → 查看 ActiBioPure™ 级别指南 → 查看 Azide Free 级别指南 → 查看 High Performance 级别指南 →
危险品化学品经营许可证（带存储）